US Broker Ratings

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 12.70% Potential Upside in the Biotech Arena

Navigating the complex world of biotechnology investments is no small feat, yet Alpha Tau Medical Ltd. (DRTS) is garnering significant attention from investors looking for promising opportunities within the healthcare..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 371% Potential Upside in the Healthcare Sector

Neuronetics, Inc. (NASDAQ: STIM), a key player in the healthcare sector’s medical devices industry, presents a compelling investment narrative, especially for investors with an appetite for high-risk, high-reward opportunities. With..

FICO (NYSE: FICO) Stock Report: Analyzing a 45.97% Potential Upside in the Technology Sector

Fair Isaac Corporation (FICO), a key player in the technology sector, continues to capture investor attention with its robust analytics software offerings. Known for its pioneering work in predictive analytics..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Unveiling a 216% Potential Upside in the Medical Devices Sector

Investors interested in the healthcare sector, particularly in the innovative realm of medical devices, may find Nano-X Imaging Ltd (NASDAQ: NNOX) an intriguing opportunity. Based in Petah Tikva, Israel, this..

Benitec Biopharma (BNTC) Stock Analysis: Unpacking a 125% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC) presents a compelling opportunity for investors with its intriguing 125.48% potential upside, according to recent analyst ratings. As a clinical-stage biotechnology firm, Benitec focuses on..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 202.59% Potential Upside

Outset Medical, Inc. (NASDAQ: OM), a prominent player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative hemodialysis solutions. Headquartered in San Jose,..

Zhengye Biotechnology Holding L (ZYBT): Investor Outlook Amidst Challenging Market Dynamics

Zhengye Biotechnology Holding Limited (ZYBT) is a notable player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic veterinary vaccines. Based in China, the..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: Exploring a 125% Upside Potential Amidst Biotech Innovations

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is capturing the attention of investors with a notable potential upside of 125.95%, according to recent analyst ratings. As a player in the biotechnology sector,..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a 53% Potential Upside Amid Innovative Genomic Solutions

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge genomic sequencing solutions. The company,..

National Research Corporation (NRC) Stock Analysis: Navigating the Healthcare Analytics Sector with a Compelling 51.24% ROE

National Research Corporation (NRC) is a noteworthy player in the healthcare sector, specializing in health information services. With a market capitalization of approximately $279.37 million, NRC is a prominent provider..

Erasca, Inc. (ERAS) Stock Analysis: Clinical-Stage Innovations with a $3.92 Billion Market Cap and High Analyst Support

Erasca, Inc. (ERAS), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its focus on precision oncology. Headquartered in San Diego, California, Erasca aims to revolutionize..

Chevron Corporation (CVX) Investor Outlook: Navigating a 3.87% Yield Amidst Market Volatility

Chevron Corporation (NYSE: CVX), a stalwart in the energy sector, continues to capture investor attention with its substantial market capitalization of $367.62 billion. As a key player in the Oil..

Senseonics Holdings, Inc. (SENS) Stock Analysis: A 138.85% Potential Upside in the Healthcare Sector

Senseonics Holdings, Inc. (SENS) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical technology company, Senseonics focuses on the development and..

Aura Biosciences, Inc. (AURA) Stock Analysis: Assessing a Potential 300% Upside in Biotech Innovation

Aura Biosciences, Inc. (NASDAQ: AURA) stands out in the biotechnology sector, attracting significant attention from investors due to its innovative approach to treating solid tumors. A clinical-stage company, Aura is..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 303% Potential Upside in Gene Therapy Innovation

Abeona Therapeutics Inc. (NASDAQ: ABEO) stands out in the biotechnology sector with its promising advancements in gene and cell therapies, targeting life-threatening diseases. With a focus on precision medicine, the..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Unpacking the 74.59% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) offers a fascinating opportunity for investors interested in the biotechnology sector, particularly those focused on innovative approaches to genetically defined diseases. With a market capitalization..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Potential 346% Upside with Innovative mRNA Therapies

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is capturing the attention of investors with its pioneering work in mRNA-based therapies and a staggering potential upside of 346.81%. The San Diego-based biotechnology..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 42.86% Potential Upside in the Cell Analysis Solutions Market

Cytek Biosciences, Inc. (NASDAQ: CTKB), a leader in the healthcare sector specializing in medical devices, has garnered notable attention from investors due to its innovative cell analysis solutions. The company,..

Rigel Pharmaceuticals (RIGL) Stock Analysis: Biotech Innovator with a 44% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a dynamic player in the biotechnology sector, is capturing investor attention with its innovative therapies and substantial growth potential. As a company focused on addressing..

agilon health, inc. (AGL) Investor Outlook: Exploring a 173% Potential Upside Despite Challenges

The healthcare sector is a dynamic arena, often characterized by rapid advancements and persistent challenges. agilon health, inc. (AGL), a company specializing in healthcare services for seniors, finds itself at..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds